10 Famous Corporate Whistleblowers in Publicly-Traded Companies
It takes a lot of guts for an individual to stand up against huge corporate entities for the overall well-being of the society.
Posts Tagged ‘NYSE:AZN’
How AstraZeneca plc (ADR) (AZN) Stacks Up Against Its Peers
At Insider Monkey we track the activity of some of the best-performing hedge funds like Appaloosa Management, Baupost, and Third Point because we determined that some of the stocks...
AstraZeneca PLC (ADR) (AZN) Cuts Jobs, Signs New Collaboration With Eli Lilly And Co (LLY)
“By diligently prioritizing, we will continue to successfully launch and commercialize new medicines, meet the needs of our customers and patients, and ultimately help AstraZeneca...
Can AstraZeneca Plc (AZN) Lung Cancer Pill Take Over Chemo Treatment?
Tagrisso, a lung cancer med from AstraZeneca plc (ADR) (NYSE:AZN) is already in early approval based on mid-stage studies, which demonstrates the possibility of it replacing the...
AstraZeneca PLC (ADR) (AZN) Relocating Jobs At U.K. Division
AstraZeneca plc (ADR) (NYSE:AZN) plans to cut some back office jobs in the U.K. as the company works toward cost-cutting and operation consolidation.
AstraZeneca PLC (ADR) (AZN), Ranbaxy Laboratories Limited (ADR) (RBXLY) Wins Over Illegal Deal Case
The 1st US Circuit Court of Appeals has recently ruled in favor of AstraZeneca plc (ADR) (NYSE:AZN) and Ranbaxy Laboratories Limited (ADR) (OTCMKTS:RBXLY) on a long-lasting class...
AstraZeneca PLC (ADR) (AZN) Retreats On Some Durvalumab Plans
AstraZeneca PLC (ADR) (NYSE:AZN) will no longer seek early regulatory review of its drug candidate durvalumab in patients with head and neck cancers.
AstraZeneca PLC (ADR) (AZN) Unveils Positive SOLO-2 Data
AstraZeneca plc (ADR) (NYSE:AZN) has recently released encouraging data from SOLO-2, a phase 3 clinical trial evaluating the efficacy of Lynparza (olaparib) as a monotherapy for...
AstraZeneca Plc (ADR) (AZN) Offloads Two Diabetes Drugs to Focus on Core Therapeutic Areas
AstraZeneca Plc (ADR) (NYSE:AZN) has once again reiterated its intention to focus on core therapeutic areas with the signing of a new commercialization agreement with a subsidiary...
Delta Air Lines Inc. (DAL), Summit Therapeutics PLC (ADR) (SMMT) & More: A Look at Five Stocks on the Move Today
Markets have opened at shaky note with major indices treading on margin.
Why Allergan, eBay, Dynavax, KBR, and More Are Trending
It's a red day on Wall Street, as all three major indexes are off by around 0.35%, potentially due to some market participants remaining on the sidelines until the Deutsche Bank...
Why These Five Stocks Are Trending Today
In this article, we examine why five companies, Dollar General Corp.
How GoPro, Suncor, and 3 Other Companies Performed During Their Latest Quarters
Crude futures are below $42 per barrel this morning as traders brace for the upcoming rig count release on Friday.
With Brexit Looming, Hedge Funds Weigh In On British Stocks
The Brexit is looming and, no matter how cute a name we can come up with, the issue is as serious as can be.
Apple (AAPL), Caterpillar (CAT), and Las Vegas Sands (LVS) Among the Day’s Trending Stocks
The markets are off to a slow start today amid a report from the Labor Department which shows that over the last week, jobless claims surged to their highest levels in a year.
Is AstraZeneca plc (ADR) (AZN) A Good Stock To Buy?
Between June 25 and October 30th the Russell 2000 ETF (IWM) has lagged the larger S&P 500 ETF (SPY) by more than 14 percentage points as investors worry over the possible ramifications...
Top Five BioTech Stocks of a Quant Hedge Fund
Massachusetts-based Arrowstreet Capital recently has issued its latest 13F filing with the Securities and Exchange Commission for the reporting quarter ended September 30.
Billionaire Andreas Halvorsen’s Four Big Winning Bets
In the investing community, Tiger Cubs occupy a special spot, most of them becoming very successful hedge fund managers and delivering strong returns for their investors.
Inovio Pharmaceuticals Inc (INO) Spikes 29% After AstraZeneca (AZN) Partnership Announcement
Inovio Pharmaceuticals Inc (NASDAQ:INO) has spiked by over 29% on Monday morning after the firm announced a strategic cancer vaccine collaboration and license agreement with...
11 Biggest Generic Drug Companies in the World
When it comes to 11 Biggest Generic Drug Companies in the World one can say that the list hasn’t changed a great deal over the years.
Pentagon Insider: Guess Who Just Won $47.6 Million Defense Contract?
For many investors, the U.S. government seems a black box.
Billionaire Steven Cohen’s Top High Dividend Stock Picks and Ones He Bets Against
Investment professionals usually recommend a balanced portfolio of stocks and bonds, something like 60% stocks and 40% bonds.
Gilead Sciences (GILD), AstraZeneca (AZN), Bellicum Pharmaceuticals (BLCM): Redmile Group’s Top New Picks
Jeremy Green’s Redmile Group entered several new positions last quarter, as revealed by the 13F Form it filed with the U.S. Securities and Exchange Commission in February.
AstraZeneca plc (ADR) (AZN) CEO Pascal Soriot Banking On Accelerated Pipeline For Rapid Development
AstraZeneca plc (ADR) (NYSE:AZN) was considered somewhat of a dying flame two years ago, according to its CEO Pascal Soriot, but now the company is set for high paced development...
Pfizer Inc. (PFE), AstraZeneca plc (ADR) (AZN) Round 2; START
The pharmaceutical industry was the focus of intense debate earlier this year owing to potential merger between Pfizer Inc. (NYSE:PFE) and AstraZeneca plc (ADR) (NYSE:AZN).
Actavis plc (ACT) Manipulating Patients to Use New Alzheimer’s Drug: NY AG’s Office
Actavis plc (NYSE:ACT) is in hot water with the New York Attorney General’s office over practices they feel are manipulative of patients.
Pfizer Inc. (PFE) To Sweeten Bid for Astrazeneca plc (ADR) (AZN): Frost & Sullivan
Ranjith Gopinathan, who is a program manager, life sciences and healthcare practice at Frost & Sullivan during an interview on CNBC said that while Merck & Co., Inc.
Druckenmiller’s 4Q13 Portfolio Changes
Stan Druckenmiller is a billionaire, and was the long-time manager of Duquesne Capital. Now, he oversees a family office, but his investing strategy is mostly the same.
Hedge Fund News: Paul Singer, George Soros & Warren Buffett
Hedge fund Elliott International has lifted its stake in German drugs distributor Celesio, bringing it close to a position where it could block the $8.3 billion takeover bid by...
Everything You Need to Know About the Upcoming Flu Season
To me, flu season is a lot like Christmas; there's a defined time period when we expect it to occur, yet it seems to appear earlier and earlier every year.
An Excellent Investment in the Biotech Space?
According to the American Cancer Society, more than 60,000 new cases of thyroid cancer will be diagnosed in the U.S., and about 1,850 people are expected to die from the disease...
Johnson & Johnson (JNJ), AstraZeneca plc (ADR) (AZN), The Procter & Gamble Company (PG): The Priceless Health Business Every Investor Overlooks
It's arguably health care's biggest name.
AstraZeneca plc (ADR) (AZN), Johnson & Johnson (JNJ): Will the Exelixis, Inc. (EXEL) Hype Catch Up to Its Valuation?
The small patient pool for medullary thyroid cancer, or MTC, isn't going to move the needle for a large pharmaceutical company. But Exelixis, Inc.
AstraZeneca plc (ADR) (AZN), Merck & Co., Inc. (MRK), Endocyte, Inc. (ECYT): Three Things You Need to Know About This Big Pharma Deal
Through the years, London-based drugmaker AstraZeneca plc (ADR) (NYSE:AZN) and U.S. pharmaceutical firm Merck & Co., Inc.
Omthera Pharmaceuticals Inc (OMTH), Elan Corporation, plc (ADR) (ELN), Onyx Pharmaceuticals, Inc. (ONXX): 3 Big Biotech Buyouts of 2013
The Chinese calendar says 2013 is the year of the snake, but the market says it's the year of biotech.
GlaxoSmithKline plc (ADR) (GSK), Theravance Inc (THRX), Teva Pharmaceutical Industries Ltd (ADR) (TEVA): Could a Pair of Respiratory Disease Treatments Save This Big Pharma?
GlaxoSmithKline plc (ADR) (NYSE:GSK) and its partner Theravance Inc (NASDAQ:THRX) recently scored a second victory in their quest to treat chronic obstructive pulmonary disease...
HFT Shenanigans: Data Leak, AstraZeneca plc (ADR) (AZN), Illiquid Crude, And Dark Pools Keep Rising
Every week Floating Path looks to highlight some of the crazier examples of HFT running amok in the markets.
Bristol Myers Squibb Co. (BMY), Merck & Co., Inc. (MRK): Is AstraZeneca plc (ADR) (AZN)’s Recent Acquisition Bigger Than Onyx?
AstraZeneca plc (ADR) (NYSE:AZN) may have missed out on acquiring the oncology platform of Onyx Pharmaceuticals, but it responded by pulling the trigger on a $500 million deal...
Theravance Inc (THRX), GlaxoSmithKline plc (ADR) (GSK): Time to Bet on This Biotech Spinoff?
There hasn't been a dull moment for investors of Theravance Inc (NASDAQ:THRX) since the company submitted an NDA for COPD/asthma drug BREO before the Food and Drug Administration...
AbbVie Inc (ABBV), AstraZeneca plc (ADR) (AZN): Neurocrine Biosciences, Inc. (NBIX) Nosedives on Mid-Stage Study Results
Investors hate to wake up and find that one of their stocks has opened nearly 30% lower than the prior day's close.
Dendreon Corporation (DNDN), ISIS Pharmaceuticals, Inc. (ISIS): Big Milestones Could Lead This Stock to Big Gains
I know it's like comparing apples and oranges, but humor me for a moment.
ISIS Pharmaceuticals, Inc. (ISIS) Scores Another Big Biotech Deal With Biogen Idec Inc. (BIIB)
Make that four collaborations between Biogen Idec Inc. (NASDAQ:BIIB) and ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) in the last two years.
Do Hedge Funds and Insiders Love AstraZeneca plc (ADR) (AZN)?
At the moment, there are dozens of gauges investors can use to track Mr. Market. A pair of the most under-the-radar are hedge fund and insider trading movement.
AstraZeneca plc (ADR) (AZN), Bristol Myers Squibb Co. (BMY), GlaxoSmithKline plc (ADR) (GSK): Diabetes Drugmakers and Their “Definitely Maybe” Moment
Over the past decade, the Food and Drug Administration has taken multiple steps to improve the process by which drugs are developed and eventually brought to market.
AstraZeneca plc (ADR) (AZN), BlackBerry Ltd (BBRY): Tuesday’s Top Upgrades (and Downgrades)
This series, brought to you by Yahoo! Finance, looks at which upgrades and downgrades make sense, and which ones investors should act on.
AbbVie Inc (ABBV): Are Hedge Funds Right About This Stock?
Now, according to many investors, hedge funds are seen as overrated, outdated investment tools of a period lost to current times.
AstraZeneca plc (ADR) (AZN), Bristol-Myers Squibb Co (BMY), BioMarin Pharmaceutical Inc. (BMRN): Three PDUFA Dates That Will Kick Off 2014
The phrase "PDUFA date" is thrown around frequently when discussing biotech and pharma companies.
Alkermes Plc (ALKS), Eli Lilly & Co. (LLY), AstraZeneca plc (ADR) (AZN): Tackling Pain and Addiction
Alkermes Plc (NASDAQ:ALKS) is primarily known for its schizophrenia and multiple sclerosis drug treatments.
Amgen, Inc. (AMGN), AstraZeneca plc (ADR) (AZN): What’s the Big Deal About Onyx Pharmaceuticals, Inc. (ONXX) Anyway?
At the end of June, Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) announced that it had rejected an offer from Amgen, Inc.
